STAANasdaqOphthalmic GoodsFiscal year ends January 2

STAAR SURGICAL CO

Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Aug 12, 2026

$21.88+0.61 (+2.87%)

Close on Oct 19, 2026

Market cap: $1.13B
P/E (TTM): 312.6
Dividend yield: –

STAAR SURGICAL CO income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2026-01-02	FY 2024 2024-12-27	FY 2023 2023-12-29	FY 2022 2022-12-30	FY 2021 2021-12-31	FY 2020 2021-01-01	FY 2019 2020-01-03	FY 2018 2018-12-28	FY 2017 2017-12-29	FY 2016 2016-12-30	FY 2015 2016-01-01	FY 2014 2015-01-02	FY 2013 2014-01-03	FY 2012 2012-12-28	FY 2011 2011-12-30	FY 2010 2010-12-31	FY 2009 2010-01-01
Revenue	239	314	322	239	230	163	150	124	91	82	77	75	72	64	63	55	51
Cost of Revenue	57	74	70	61	52	45	38	32	26	24	24	26	22	19	20	20	20
Gross Profit	182	240	253	223	179	118	112	92	64	58	53	49	50	44	42	35	31
Research & Development	40	45	40	36	34	32	25	22	20	21	15	12	6.71	6.44	5.87	5.72	5.89
Selling, General & Admin	274	252	225	180	145	112	100	85	68	71	43	44	41	36	33	32	30
Selling & Marketing	103	117	112	89	67	46	45	39	28	29	24	26	24	21	18	17	15
General & Administrative	86	90	72	55	44	34	29	24	19	22	20	18	17	15	15	15	15
Advertising Expenses	20	34	47	38	22	11	12	8.98	6.10	6.16	3.92	2.80	2.10	1.80	1.31	1.20	–
Operating Income	-92	-13	28	44	33	6.77	12	6.60	-3.63	-13	-5.34	-8.03	0.70	-1.22	2.78	-2.60	-4.88
Interest Expense	–	–	–	–	–	–	–	–	0.11	0.11	0.08	0.15	0.17	0.29	0.52	0.90	1.32
Interest & Investment Income	–	–	–	–	–	–	–	–	–	0.00	0.05	0.05	0.06	0.06	0.03	0.04	0.07
Other Non-Operating Income	9.45	3.56	5.60	1.75	-2.04	1.50	1.17	0.04	1.34	0.21	-0.27	-0.62	0.41	0.70	-0.08	-1.08	-0.87
Merger & Restructuring Charges	29	–	–	–	–	–	–	–	–	–	–	0.32	2.24	2.64	1.06	–	–
Gain (Loss) on Sale of Assets	-0.07	-1.69	-0.07	-0.07	0.00	-0.21	-0.01	-0.01	-0.62	-0.22	0	0	-0.20	-0.13	-0.01	0.00	-0.10
Pretax Income	-82	-9.05	34	46	31	8.27	13	6.64	-2.30	-12	-5.61	-8.65	1.11	-0.52	2.70	-3.68	-5.75
Income Tax Expense	-1.82	11	12	5.89	3.79	2.35	-1.02	1.67	-0.16	-0.32	0.93	-0.25	0.72	1.24	1.36	0.43	1.15
Income from Continuing Operations	–	–	–	–	–	–	–	–	–	–	–	–	–	-1.76	1.35	-4.11	-6.90
Income from Discontinued Operations	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	4.17	0.70
Net Income	-80	-20	21	40	28	5.91	14	4.97	-2.14	-12	-6.53	-8.39	0.40	-1.76	1.35	0.05	-6.20
EPS (Basic)(per share)	-1.62	-0.41	0.44	0.83	0.58	0.13	0.32	0.12	-0.05	-0.30	-0.17	-0.22	0.01	-0.05	0.04	0.00	-0.19
EPS (Diluted)(per share)	-1.62	-0.41	0.43	0.80	0.56	0.12	0.30	0.11	-0.05	-0.30	-0.17	-0.22	0.01	-0.05	0.04	0.00	-0.19
Shares Outstanding (Basic, Weighted)(shares)	50	49	49	48	47	46	44	43	41	40	39	38	37	36	35	0.03	32
Shares Outstanding (Diluted, Weighted)(shares)	50	49	49	49	49	48	47	45	41	40	39	38	39	36	37	0.03	32

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jul 3, 2026

Profitability, TTM

Gross margin: 76.6%
Operating margin: 4.0%
Net margin: 1.1%
Return on equity, FY2025: -21.7%

Financial strength

Current ratio: 4.66
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 202.4%

Valuation

P/E ratio: 312.6
Price to sales: 3.32
Price to book: 3.08
Dividend yield: –